Open Tender Watch
Menu v
ACCESS EN PT
← Companies Company PT

GENERIS - FARMACÊUTICA, S.A.

NIF 508107997
↓ CSV ↓ JSON
Risk Flags
A1 · Repeat Direct Award €7,043,573 118 contracts
Same supplier receives ≥2 direct awards in 36 months with cumulative value above the CCP Art. 113 §2 statutory cap
HIGH €7,043,573 118 contracts
A2 · Late Publication €18,355,902,852 10,381 contracts
Contract published to BASE more than 10 days after the signing date
LOW €18,355,902,852 10,381 contracts
A5 · Threshold Splitting €75,736,676 296 contracts
Contract value falls within 5% below a procedural threshold (€5K / €20K / €75K / €150K / €5.35M). Score: 35 · Severity: Medium.
HIGH €75,736,676 296 contracts
A6 · Low Competition €155,761 16 contracts
Only one bidder participated in a competitive procedure
MEDIUM €155,761 16 contracts
A9 · Price Overrun €13,267 6 contracts
Effective price exceeds base price by >50% (score 30) or >100% (score 55); or effective price is <50% of base (score 10, possible predatory bid or data error). Severity: Medium/High/Low.
HIGH €13,208 5 contracts
MEDIUM €59 1 contracts
A9 · Abnormal Price Reduction €23,077,439,427 7,694 contracts
Effective price exceeds base price by >50% (score 30) or >100% (score 55); or effective price is <50% of base (score 10, possible predatory bid or data error). Severity: Medium/High/Low.
LOW €23,077,439,427 7,694 contracts
C3 · Missing Mandatory Fields €4,915,950 219 contracts
CPV code, procedure type, or base price absent for the procedure type, or base price exceeds ±€1 trillion (implausible data entry). Score: 20 · Severity: Low.
LOW €4,915,950 219 contracts

Procurement Network

Aggregated links between this entity and connected counterparties

Public view excludes person-level links and tax identifiers.

Loading network…
Legend Focus entity Public body Company Anonymized individual

Contracts by Contracting Authority

1,254
€2,475,643,734
1,539
€914,742,692
274
€823,251,857
408
€813,806,885
529
€768,429,168
245
€750,719,182
451
€748,806,350
92
€744,650,011
189
€706,536,301
557
€702,514,605
549
€686,966,748
92
€685,711,811
1,075
€683,061,340
153
€671,715,271
155
€656,636,220
357
€648,520,132
155
€643,716,446
213
€640,246,758
154
€635,157,566
212
€619,921,591
Page 1 of 4 · 73 authorities
Next →

All Contracts Won

Signal: All A1 · Repeat Direct Award A2 · Late Publication A5 · Threshold Splitting A6 · Low Competition A9 · Price Overrun A9 · Abnormal Price Reduction C3 · Missing Mandatory Fields

Page 1 of 290 · 14,458 contracts

Q1/978/2020 Medicamentos diversos
PT · 6519917 · Ajuste direto simplifi...
€0
201G000963-NoraDRENALina 1 mg/mL Sol inj Fr 10 mL I
PT · 6505245 · Ajuste direto simplifi...
€0
AM 12 693/2020 - Aquisição de Ribavirina 400mg
PT · 6532691 · Ajuste direto simplifi...
€0
99/01300_3.11/2020 - Aq. Medicamentos emergentes com AQ's (COVID_99)
PT · 7243393 · Ajuste direto simplifi...
€0
04/01317.11/2020 - Aquisição de hidrocortisona 100 mg pó sol inj fr im iv (Covid-19)
PT · 7243423 · Ajuste direto simplifi...
€0
99/01403_1.11/2020 - Aquisição de Medicamentos ao abrigo do AQ's (covid-19)
PT · 7243648 · Ajuste direto simplifi...
€0
AZITROMICINA 500MG COMP REV - COVID 19
PT · 6565858 · Ajuste direto simplifi...
€0
11/03446.11/2020 - Aquisição de metRONIDAZOL, Tramadol e gliBENCLAMida
PT · 7359176 · Ajuste direto simplifi...
€0
Noradrenalina 1 mg/ml Sol inj Fr 10 ml IV
PT · 7388023 · Ajuste direto simplifi...
€0
Aquisição de medicamentos (Acido valproico; Azitromicina; Captopril; Dlazepam; Dobutamina, Hidrocortisona; Meropenem e Paracetamol)
PT · 6744110 · Ajuste direto simplifi...
€0
Acido valproico 400 mg Po sol inj Fr IV
PT · 6783005 · Ajuste direto simplifi...
€0
S1/2570/2020 Captopril 25 mg e Irbesartan 150mg - COVID 19
PT · 6878222 · Ajuste direto simplifi...
€0
99/01412_2.11/2020 - Aquisição de Medicamentos emergentes abrigo dos AQ's (covid-19)
PT · 7243688 · Ajuste direto simplifi...
€0
Ondansetrom 8 mg Comp
PT · 7270504 · Ajuste direto simplifi...
€0
traMADOL 100 mg/2 ml Sol inj Fr 2 ml IM IV SC
PT · 7270746 · Ajuste direto simplifi...
€0
traMADOL 100 mg/ml Sol oral Fr 10 ml
PT · 7270772 · Ajuste direto simplifi...
€0
Paracetamol 500 mg Comp
PT · 7270102 · Ajuste direto simplifi...
€0
99/01607.11/2020 - Aquisição de amoxicilina 1000 mg + ácido clavulânico 200 mg pó sol inj fr iv (covid-19)
PT · 7243748 · Ajuste direto simplifi...
€0
traMADOL 50 mg Caps
PT · 7270793 · Ajuste direto simplifi...
€0
04/03482.11/2020 - Aquisição de amoxicilinas e azitromicina 500mg
PT · 7321533 · Ajuste direto simplifi...
€0
11/04176.11/2020 - Aquisição de metRONIDAZOL 5 mg/ml Sol inj Fr 200 ml IV
PT · 7334879 · Ajuste direto simplifi...
€0
04/03485.11/2020 - Aquisição de MEROpenem 1000 mg Pó sol inj Fr IV
PT · 7321549 · Ajuste direto simplifi...
€0
04/03508.11/2020 - Aquisição de paracetamol comp e inj
PT · 7321579 · Ajuste direto simplifi...
€0
11/04407.11/2020 - Aquisição de MEROpenem 1000 mg Pó sol inj Fr IV
PT · 7358857 · Ajuste direto simplifi...
€0
63002620
PT · 7323266 · Ajuste direto simplifi...
€0
Paracetamol 500 mg Comp
PT · 7387996 · Ajuste direto simplifi...
€0
traMADOL 100 mg/2 ml Sol inj Fr 2 ml IM IV SC
PT · 7388009 · Ajuste direto simplifi...
€0
Hidrocortisona 100 mg Po sol inj Fr IM IV
PT · 7387939 · Ajuste direto simplifi...
€0
amLODIPina 5 mg Comp
PT · 7387988 · Ajuste direto simplifi...
€0
11/03459.11/2020 - Aquisição de diazepan cânula, lorazepan 2.5mg e metformina 500mg
PT · 7358568 · Ajuste direto simplifi...
€0
CS/157/2020 - Aquisição de Medicamentos Gerais - COVID-19
PT · 7573980 · Ajuste direto simplifi...
€0
iBUPROfeno 200 mg Comp
PT · 7387927 · Ajuste direto simplifi...
€0
Linezolida 600 mg Comp
PT · 7506771 · Ajuste direto simplifi...
€0
Noradrenalina 1 mg/ml Sol inj Fr 10 ml IV
PT · 7506773 · Ajuste direto simplifi...
€0
Paracetamol 500 mg Comp
PT · 7537878 · Ajuste direto simplifi...
€0
Linezolida 600 mg Comp
PT · 7651348 · Ajuste direto simplifi...
€0
Azitromicina 500 mg Comp
PT · 7651330 · Ajuste direto simplifi...
€0
Paracetamol 500 mg Comp
PT · 7651319 · Ajuste direto simplifi...
€0
Amoxicilina 500 mg Caps
PT · 7651357 · Ajuste direto simplifi...
€0
14006621 - LINEZOLIDA
PT · 7716458 · Ajuste direto simplifi...
€0
Levetiracetam 1000 mg Comp
PT · 7716632 · Ajuste direto simplifi...
€0
14026721 - AMOXICILINA + ÁCIDO CLAVULÂNICO
PT · 7716975 · Ajuste direto simplifi...
€0
Paracetamol 500 mg Comp
PT · 7716591 · Ajuste direto simplifi...
€0
iBUPROfeno 200 mg Comp
PT · 7716607 · Ajuste direto simplifi...
€0
traMADOL 100 mg/2 ml Sol inj Fr 2 ml IM IV SC
PT · 7716622 · Ajuste direto simplifi...
€0
14013521 - AMIODARONA
PT · 7716755 · Ajuste direto simplifi...
€0
Linezolida 600 mg Comp
PT · 7807610 · Ajuste direto simplifi...
€0
Azitromicina 500 mg Comp
PT · 7813838 · Ajuste direto simplifi...
€0
Paracetamol 500 mg Comp
PT · 7813912 · Ajuste direto simplifi...
€0
Hidrocortisona 100 mg Po sol inj Fr IM IV
PT · 7807587 · Ajuste direto simplifi...
€0
Next →
Overview
Total Value Won
€23,189,380,103
Contracts Won
14,458
Score 513445 · CRITICAL RISK
NIF
508107997
Country
PT
Directors & Officers

Personal data is pseudonymised for public access. Authenticate with a journalist token to view full names and NIFs.

  • A.C. [P-6b27]
    Vogal
    since 2009-01-27
  • B.T. [P-5d15]
    Vogal
    since 2013-06-18
  • B.V. [P-41c8]
    Vogal
    since 2022-11-21
  • B.V. [P-41c8]
    Vogal
    since 2024-07-02
  • B.M. [P-4414]
    Vogal
    since 2013-06-18
  • D.A. [P-c2b1]
    Administrador
    since 2024-07-02
  • J.M. [P-4b91]
    Vogal
    since 2021-02-17
  • J.M. [P-4b91]
    Vogal
    since 2024-07-02
  • J.P. [P-a3d6]
    Vogal
    since 2024-07-02
  • J.M. [P-8a35]
    Presidente
    since 2013-06-18
  • J.D. [P-6dab]
    Vogal
    since 2009-01-27
  • J.L. [P-4e77]
    Vogal
    since 2009-01-27
  • J.P. [P-e7f5]
    Vogal
    since 2009-01-27
  • L.S. [P-58df]
    Presidente
    since 2021-02-17
  • L.S. [P-58df]
    Presidente
    since 2024-07-02
  • L.M. [P-cd63]
    Vogal
    since 2020-05-22
  • L.M. [P-cd63]
    Vogal
    since 2021-02-17
  • L.M. [P-cd63]
    Vogal
    since 2024-07-02
  • P.M. [P-976f]
    Administrador delegado - nomeado por cooptação
    since 2010-07-22
  • P.M. [P-976f]
    Vogal
    since 2013-06-18
  • P.P. [P-9c70]
    vogal
    since 2017-04-28
  • R.I. [P-424a]
    Vogal
    since 2021-02-17
  • R.I. [P-424a]
    Vogal
    since 2024-07-02
  • S.I. [P-c50b]
    Presidente
    since 2017-04-28
  • S.I. [P-c50b]
    Presidente
    since 2021-02-17
  • S.B. [P-2395]
    Vogal
    since 2019-05-15
  • S.B. [P-2395]
    Vogal
    since 2021-02-17
  • S.B. [P-2395]
    Vogal
    since 2024-07-02
  • V.M. [P-4ee7]
    vogal
    since 2017-04-28
  • V.M. [P-4ee7]
    Vogal
    since 2021-02-17
  • V.M. [P-4ee7]
    Presidente
    since 2024-07-02
  • C.L. [P-db3e]
    Fiscal Único
    since 2010-10-07
  • D.A. [P-c2b1]
    Fiscal Único
    since 2010-10-07
  • N.M. [P-c64f]
    Fiscal Único
    since 2009-01-19
  • P.R. [P-24a4]
    Fiscal Único
    since 2009-01-19
  • M.J. [P-082f]
    Sócio
    since 2007-09-20
  • P.M. [P-5bef]
    Sócio
    since 2007-09-20
  • A.C. [P-6b27]
    Vogal
    2013-06-18 → 2016-10-03
  • A.P. [P-d6ac]
    Vogal
    2009-01-27 → 2012-04-02
  • B.D. [P-3fbe]
    Vogal
    2009-01-27 → 2010-07-22
  • J.D. [P-6dab]
    Vogal
    2013-06-18 → 2016-12-29
  • J.P. [P-141b]
    Vogal
    2009-01-27 → 2010-07-21
  • J.L. [P-4e77]
    Presidente
    2013-06-18 → 2017-04-28
  • J.P. [P-e7f5]
    Vogal
    2013-06-18 → 2017-04-28
  • M.P. [P-7d24]
    vogal
    2017-04-28 → 2018-03-16
  • P.M. [P-976f]
    Vogal
    2017-04-28 → 2020-05-22
  • P.M. [P-63d9]
    Administrador
    2012-11-09 → 2013-03-06
  • P.M. [P-b036]
    Vogal
    2018-06-12 → 2019-05-15
  • P.P. [P-9c70]
    Vogal
    2021-02-17 → 2022-09-29
  • P.M. [P-be5a]
    Presidente
    2009-01-27 → 2010-07-21
  • N.M. [P-c64f]
    Fiscal Único
    until 2010-08-31
  • P.R. [P-24a4]
    Fiscal Único
    until 2010-08-31
Ownership & Registries

Beneficial ownership data (shareholders, directors, ultimate beneficial owners) is not yet imported. Links below open external public registries.

Registo Comercial (MJ) ↗ RCBE — Beneficial Ownership Register ↗

Full RCBE access requires judicial authentication (CJEU 2022 ruling limits public exposure).

Search in TED (EU procurement) ↗
Phase 7 — ownership layer planned